Thromboinflammation response to tocilizumab in COVID-19.

Gergi, Mansour; Cushman, Mary; Littenberg, Benjamin; Budd, Ralph C

Gergi, Mansour; Cushman, Mary; Littenberg, Benjamin; Budd, Ralph C.

Afiliação

Gergi M; Division of Hematology and Oncology Department of Medicine Larner College of Medicine University of Vermont Burlington VT USA.
Cushman M; Division of Hematology and Oncology Department of Medicine Larner College of Medicine University of Vermont Burlington VT USA.
Littenberg B; Division of General Internal Medicine Research Department of Medicine Larner College of Medicine University of Vermont Burlington VT USA.
Budd RC; Department of Medicine Vermont Center for Immunology and Infectious Diseases Larner College of Medicine University of Vermont Burlington VT USA.

Res Pract Thromb Haemost ; 4(8): 1262-1268, 2020 Nov.

Article em En | MEDLINE | ID: mdl-33043232

Palavras-chave

COVID19; COVID19 coagulopathy; interleukin6; thromboinflammation; tocilizumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google